SOAT1 and staphylococcal pneumonia: To determine how baricitinib inhibition of the JAK/STAT pathway affects inflammation in the lungs during influenza infection, staphylococcal pneumonia, and post‐influenza MRSA pneumonia, we measured inflammatory cytokines in lung homogenates.